| 1. | | Completed | 12 week,comparing safety of HMR1964 & insulin aspart used in continuous subcutaneous infusion in type 1 diabetes.
Condition: Diabetes, type I |
| 2. | | Not yet recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 3. | | Not yet recruiting | 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 4. | | Recruiting | 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection
Conditions: stage I breast cancer; stage II breast cancer |
| 5. | | No longer recruiting | ABI-007 in Taxol Resistant Patients with Metastatic Breast Cancer
Conditions: Breast Neoplasms; Metastases, Neoplasm |
| 6. | | Recruiting | ABI-007, Carboplatin, and Trastuzumab in Treating Patients With HER2/neu-Overexpressing Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 7. | | Completed | Achilles Tendon Lengthening in Patients with Diabetes to Prevent Foot Ulcers
Conditions: Diabetes Mellitus; Foot Ulcer; Peripheral Neuropathy |
| 8. | | Recruiting | Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Conditions: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus; ... |
| 9. | | Recruiting | Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
Conditions: Breast Cancer; nausea and vomiting |
| 10. | | Completed | Acupuncture for Shortness of Breath in Cancer Patients
Conditions: Lung Neoplasms; Breast Neoplasms |
| 11. | | Recruiting | Acupuncture for the Treatment of Hot Flashes in Breast Cancer Patients
Conditions: Breast Neoplasms; Hot Flashes |
| 12. | | Not yet recruiting | Acupuncture for Women's Health Conditions
Conditions: Ovarian Neoplasms; Endometriosis; Pelvic Pain; Uterine Neoplasms |
| 13. | | No longer recruiting | Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
Condition: Ovarian Cancer |
| 14. | | Recruiting | Acute Glycemic Effects of a Very Low Fat Diet in Type 2 Diabetes
Condition: Diabetes Mellitus, Non-Insulin-Dependent |
| 15. | | Completed | Acute regulation of parathyroid hormone by dietary phosphate
Condition: Secondary Hyperparathyroidism |
| 16. | | No longer recruiting | Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Conditions: stage IIIB breast cancer; stage IIIA breast cancer; inflammatory breast cancer; stage II breast cancer |
| 17. | | No longer recruiting | Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 18. | | Completed | Adiposity and Fat Patterning in Black Americans
Conditions: Heart Diseases; Diabetes Mellitus; Obesity |
| 19. | | Recruiting | Adjuvant Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer
Conditions: bone metastases; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer |
| 20. | | No longer recruiting | Adjuvant Chemotherapy Compared With Observation in Treating Patients With Resected Early Stage Ovarian Epithelial Cancer
Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer |
| 21. | | Recruiting | Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer
Conditions: recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer |
| 22. | | Recruiting | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer
Condition: stage I breast cancer |
| 23. | | Recruiting | Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer; Male Breast Cancer |
| 24. | | No longer recruiting | Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer
Conditions: Male Breast Cancer; stage II breast cancer; stage IIIA breast cancer |
| 25. | | No longer recruiting | Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer |
| 26. | | Recruiting | Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; breast cancer in situ |
| 27. | | Recruiting | Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 28. | | Recruiting | Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
Conditions: intraductal breast carcinoma; breast cancer in situ |
| 29. | | Recruiting | Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
Conditions: intraductal breast carcinoma; breast cancer in situ |
| 30. | | Completed | African-American Diabetes Intervention Project
Condition: Insulin-Dependent Diabetes Mellitus |
| 31. | | Recruiting | Aging and Cellular Mechanism for Insulin Action after Exercise Training
Condition: Diabetes Mellitus |
| 32. | | No longer recruiting | ALIMTA (Pemetrexed) as First Line Chemotherapy for Advanced Breast Cancer
Condition: Breast Cancer |
| 33. | | No longer recruiting | ALIMTA (pemetrexed) Plus Carboplatin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer
Conditions: Breast Cancer; Neoplasm Metastasis |
| 34. | | Recruiting | Alimta (pemetrexed) plus Gemzar (gemcitabine) in metastatic breast cancer patients after receiving Taxane therapy.
Condition: Breast Cancer |
| 35. | | No longer recruiting | Allogeneic (Donor) Bone Marrow Transplant to Treat Breast Cancer
Conditions: Breast Cancer; Breast Neoplasm |
| 36. | | Recruiting | Allogeneic Peripheral Stem Cell Transplantation After Antithymocyte Globulin, High-Dose Melphalan, and Fludarabine in Treating Women With Metastatic Adenocarcinoma of the Breast
Conditions: recurrent breast cancer; stage IV breast cancer |
| 37. | | Recruiting | AMG 162 in Biphosphonate Naive Metastatic Breast Cancer
Conditions: Breast Cancer; Metastases |
| 38. | | Recruiting | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer
Condition: Breast Cancer |
| 39. | | No longer recruiting | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Conditions: Lung Cancer; Ovarian Cancer; Lymphoma; Leukemia; Breast Cancer |
| 40. | | No longer recruiting | Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
Conditions: stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ... |
| 41. | | Recruiting | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Conditions: adult solid tumor; Breast Cancer; Lung Cancer; neurotoxicity; ovarian epithelial cancer; Prostate Cancer |
| 42. | | Recruiting | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy
Conditions: Endocrine Cancer; female reproductive cancer; neurotoxicity |
| 43. | | Completed | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Conditions: Endometrial Cancer; ovarian epithelial cancer; Cervical Cancer; uterine sarcoma |
| 44. | | No longer recruiting | Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors
Conditions: childhood soft tissue sarcoma; childhood liver cancer; adult soft tissue sarcoma; Bone Cancer; ovarian sarcoma; Testicular Cancer; Brain Tumor; ... |
| 45. | | No longer recruiting | Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 46. | | No longer recruiting | Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer
Condition: recurrent ovarian epithelial cancer |
| 47. | | Completed | Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
Conditions: stage IV breast cancer; recurrent breast cancer |
| 48. | | Recruiting | Analysis of Brain Metastasis in Patients with Breast Cancer, with and without Over-Expression of HER-2
Condition: Breast Neoplasms |
| 49. | | Recruiting | Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer |
| 50. | | Recruiting | Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Conditions: recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer |
